Literature DB >> 10707958

The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.

P W Jurutka1, L S Remus, G K Whitfield, P D Thompson, J C Hsieh, H Zitzer, P Tavakkoli, M A Galligan, H T Dang, C A Haussler, M R Haussler.   

Abstract

The human vitamin D receptor (hVDR) is a ligand-regulated transcription factor that mediates the actions of the 1,25-dihydroxyvitamin D3 hormone to effect bone mineral homeostasis. Employing mutational analysis, we characterized Arg-18/Arg-22, hVDR residues immediately N-terminal of the first DNA binding zinc finger, as vital for contact with human basal transcription factor IIB (TFIIB). Alteration of either of these basic amino acids to alanine also compromised hVDR transcriptional activity. In contrast, an artificial hVDR truncation devoid of the first 12 residues displayed both enhanced interaction with TFIIB and transactivation. Similarly, a natural polymorphic variant of hVDR, termed F/M4 (missing a FokI restriction site), which lacks only the first three amino acids (including Glu-2), interacted more efficiently with TFIIB and also possessed elevated transcriptional activity compared with the full-length (f/M1) receptor. It is concluded that the functioning of positively charged Arg-18/Arg-22 as part of an hVDR docking site for TFIIB is influenced by the composition of the adjacent polymorphic N terminus. Increased transactivation by the F/M4 neomorphic hVDR is hypothesized to result from its demonstrated enhanced association with TFIIB. This proposal is supported by the observed conversion of f/M1 hVDR activity to that of F/M4 hVDR, either by overexpression of TFIIB or neutralization of the acidic Glu-2 by replacement with alanine in f/M1 hVDR. Because the f VDR genotype has been associated with lower bone mineral density in diverse populations, one factor contributing to a genetic predisposition to osteoporosis may be the F/f polymorphism that dictates VDR isoforms with differential TFIIB interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707958     DOI: 10.1210/mend.14.3.0435

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  98 in total

Review 1.  Molecular nature of the vitamin D receptor and its role in regulation of gene expression.

Authors:  P W Jurutka; G K Whitfield; J C Hsieh; P D Thompson; C A Haussler; M R Haussler
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Meta-Analysis of the Association Between the rs228570 Vitamin D Receptor Gene Polymorphism and Arterial Hypertension Risk.

Authors:  Ivone F O C Nunes; Ana A C M Cavalcante; Marcus V O B Alencar; Marcos D F Carvalho; José L R Sarmento; Nayra S C C A Teixeira; Adriana A Paiva; Lídia R Carvalho; Leopoldo F M Nascimento; Maria S P Cruz; Marcelo M Rogero; Andréia C B Lima; Cecilia M R G Carvalho
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

3.  Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population.

Authors:  Wani Arjumand; Shiekh Tanveer Ahmad; Amlesh Seth; Ashish Kumar Saini; Sarwat Sultana
Journal:  Tumour Biol       Date:  2011-09-20

Review 4.  Systems genetics of mineral metabolism.

Authors:  James C Fleet; Rebecca Replogle; David E Salt
Journal:  J Nutr       Date:  2011-01-26       Impact factor: 4.798

Review 5.  Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors.

Authors:  James C Fleet; Ryan D Schoch
Journal:  Crit Rev Clin Lab Sci       Date:  2010-08       Impact factor: 6.250

Review 6.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

7.  Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Michael E Carney; Rachel T Palmieri; Paul D P Pharoah; Honglin Song; Estrid Hogdall; Susanne Kruger Kjaer; Richard A DiCioccio; Valerie McGuire; Alice S Whittemore; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Marc T Goodman
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

Review 8.  Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies.

Authors:  Kalthoum Tizaoui; Anissa Berraies; Besma Hamdi; Wajih Kaabachi; Kamel Hamzaoui; Agnès Hamzaoui
Journal:  Lung       Date:  2014-09-30       Impact factor: 2.584

9.  A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression.

Authors:  Alanna Roff; Robin Taylor Wilson
Journal:  J Steroid Biochem Mol Biol       Date:  2008-09-06       Impact factor: 4.292

10.  Interaction of vitamin D receptor with HLA DRB1 0301 in type 1 diabetes patients from North India.

Authors:  Neetu Israni; Ravinder Goswami; Avinash Kumar; Rajni Rani
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.